Stocks / GILD
GILD stock forecast
GILEAD SCIENCES INC · Healthcare · Drug Manufacturers - General
Where this rating comes from: The Upfront Model, whose picks have been recorded with a fingerprint the day they publish since September 18, 2026. See the record.
GILD is not among the 20 largest holdings published for 2026 Q4. See the portfolio
GILD against the S&P 500
| Period | GILD | S&P 500 (SPY) |
|---|---|---|
| 1 month | +10.4% | -4.7% |
| 3 months | +15.1% | -4.8% |
| Year to date | +40.1% | +7.9% |
| 1 year | +36.1% | +11.8% |
Total return, dividends included.
Key numbers
| Price | $168.98 |
| Market cap | 209.59 Billion |
| P/E (trailing 12 months) | -54.5 |
| P/S (trailing 12 months) | 6.8 |
| P/B (latest quarter) | 16.2 |
| Gross margin | 79.9% |
| Net profit margin | -12.5% |
| Return on equity | -21.7% |
| Beta | 0.4 |
As of October 30, 2026.
GILD and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| AMGN | AMGEN INC | 240.11 Billion | Outperform | AMGN vs GILD |
| PFE | PFIZER INC | 159.94 Billion | Greatly Outperform | GILD vs PFE |
| BMY | BRISTOL MYERS SQUIBB CO | 121.75 Billion | Greatly Outperform | GILD vs BMY |
| MRK | MERCK & CO INC | 339.66 Billion | Greatly Outperform | MRK vs GILD |
| BIIB | BIOGEN INC | 37.16 Billion | Greatly Outperform | GILD vs BIIB |
| ABBV | ABBVIE INC | 505.56 Billion | Outperform |
Questions
What does the Upfront Investment model say about GILD?
The model rates GILEAD SCIENCES INC (GILD) "Outperform" as of November 18, 2026, which means its medium-term return forecast is above the middle of the stocks the model scores, but outside the top fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the GILD rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is GILD in the Upfront Investment model portfolio?
GILD is not among the 20 largest holdings published for 2026 Q4.
The rating is generated by The Upfront Model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.